Celyad to Present Update to r/r AML and MDS Program at 2019 ASH Annual Meeting
Celyad Oncology SA - American Depositary Shares (CYAD)
US:NASDAQ Investor Relations:
celyad.com/en/investors
Company Research
Source: Business Wire
Management to host an analyst and investor event to review data from American Society of Hematology (ASH) on Monday, Dec. 9, at 8:30 p.m. ET MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News:Celyad (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced that three abstracts related to the company’s autologous NKG2D-based CAR-T candidates for the treatment of relapsed/refractory acute myeloid leukemia (r/r AML) and myelodysplastic syndromes (MDS) have been accepted for presentation at the 61st American Society of Hematology (ASH) Annual Meeting, which will be held from December 7-10, 2019, in Orlando, Florida. In addition, management will host a live event at ASH for analysts and investors on Monday, December 9, to review the data from the three posters, as well as updates to the company’s development program for r/r AML and MDS and proprietary OptimAb manufacturing process
Show less
Read more
Impact Snapshot
Event Time:
CYAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYAD alerts
High impacting Celyad Oncology SA - American Depositary Shares news events
Weekly update
A roundup of the hottest topics